Eligo Bioscience

Developer of antibiotics intended to treat microbiome precision and bacteria-associated diseases. The company's antibiotics combine sequencing systems with engineered phage capsids, to develop antimicrobials that are used to eradicate resistant pathogens or virulent bacteria within the human microbiome, enabling pharmaceutical companies to make medicines from pathogen-resistant antimicrobials.

Khosla Ventures

🏥 Healthcare